April 22, 2015 — IBA (Ion Beam Applications S.A.) announced that it has signed a formal contract with the University Medical Center Groningen (UMCG) to establish The Netherlands’ first proton therapy center in Groningen.
IBA will equip the new center with its Proteus PLUS two-gantry room configuration, including its next-generation pencil beam scanning and cone beam computed tomography (CBCT) capabilities. The contract — as noted in IBA’s press release dated June 20, 2014 — will also include a long-term operation and maintenance agreement. The equipment and services that will be supplied by IBA are worth approximately EUR 50 million to IBA.
“The professional support and responsiveness that IBA has demonstrated throughout our demanding tender procedure give us confidence in a successful and long lasting collaboration with them. We are now eager to see the Proton Therapy center opening its doors in 2017 and to provide this technology for the benefit of thousands of cancer patients in Holland”, said Bert-Jan Souman, managing director of the Proton Therapy Center Groningen at the UMCG.
For more information: www.iba-worldwide.com